La hiponatremia: un desafío clínico y terapéutico. Cuando no parece lo que es

Paula Luque-Linero; Jaime Sánchez-Sánchez; Eduardo Carmona-Nimo

doi:10.32818/reccmi.a9s1a9

Authors

Paula Luque-Linero Internal Medicine Department, Virgen Macarena University Hospital, Seville, Spain https://orcid.org/0000-0001-5150-4207
Jaime Sánchez-Sánchez Internal Medicine Department, Hospital Minas de Río Tinto, Huelva, Spain
Eduardo Carmona-Nimo Internal Medicine Department, Virgen Macarena University Hospital, Seville, Spain

DOI:

https://doi.org/10.32818/reccmi.a9s1a9

Keywords:

hyponatremia, SIADH, tuberculosis, urea

Abstract

Syndrome of inappropriate antidiuretic hormone secretion (SIADH) is a diagnosis of exclusion in patients suffering from hyponatremia. The etiology can be diverse, with pulmonary tuberculosis being a described but rare cause. Urea is proposed as an effective drug in the treatment of hyponatremia due to SIADH. We present the case of a patient with SIADH secondary to pulmonary tuberculosis, whose hyponatremia improved after treatment with urea.

Downloads

Download data is not yet available.

Metrics

Metrics Loading ...

References

Turkmen E, Karatas A, Altindal M. Factors affecting prognosis of the patients with severe hyponatremia. Nefrologia (Engl Ed). 2022; 42(2): 196-202. doi: https://doi.org/10.1016/j.nefroe.2022.05.002 (último acceso sept. 2024). DOI: https://doi.org/10.1016/j.nefro.2021.03.007

Poch E, Molina A, Piñeiro G. Síndrome de secreción inadecuada de hormona antidiurética. Med Clin (Barc). 2022; 159(3): 139-146. doi: https://doi.org/10.1016/j.medcli.2022.02.015 (último acceso sept. 2024). DOI: https://doi.org/10.1016/j.medcli.2022.02.015

Martínez González Á, Valle Feijoo L, de la Fuente Aguado J, González Nunes M. Tratamiento de la hiponatremia por SIADH con urea oral. Med Clin (Barc). 2024; 162(6): 303-304. doi: https://doi.org/10.1016/j.medcli.2023.10.017 (último acceso sept. 2024). DOI: https://doi.org/10.1016/j.medcli.2023.10.017

Yoshida T, Masuyama H, Yamagata H, Miyabayashi M, Onishi S, Inaba Y, Takemoto M. The incidence and risk factors of hyponatremia in pulmonary tuberculosis. J Endocr Soc. 2022; 6(11): bvac130. doi: https://doi.org/10.1210/jendso/bvac130 (último acceso sept. 2024). DOI: https://doi.org/10.1210/jendso/bvac130

Bal C, Gompelmann D, Krebs M, Antoniewicz L, Guttmann-Ducke C, Lehmann A, et al. Associations of hyponatremia and SIADH with increased mortality, young age and infection parameters in patients with tuberculosis. PLoS One. 2022; 17(10): e0275827. doi: https://doi.org/10.1371/journal.pone.0275827 (último acceso sept. 2024). DOI: https://doi.org/10.1371/journal.pone.0275827

Manzanares W, Aramendi I, Langlois PL, Biestro A. Hiponatremias en el paciente neurocrítico: enfoque terapéutico basado en la evidencia actual. Med Intensiva. 2015; 39(4): 234-243. doi: https://doi.org/10.1016/j.medin.2014.11.004 (último acceso sept. 2024). DOI: https://doi.org/10.1016/j.medin.2014.11.004

Paudel S, Dhanani M, Patel KH, Vakkalagadda NP, Sanker V, Damera AR, et al. Pulmonary tuberculosis in an adult presenting with severe hyponatremia: a case report and review of literature. Clin Case Rep. 2024; 12(2): e8469. doi: https://doi.org/10.1002/ccr3.8469 (último acceso sept. 2024). DOI: https://doi.org/10.1002/ccr3.8469

Barajas Galindo DE, Ruiz-Sánchez JG, Fernández Martínez A, de la Vega IR, Ferrer García JC, Ropero-Luis G, et al. Consensus document on the management of hyponatraemia of the Acqua Group of the Spanish Society of Endocrinology and Nutrition. Endocrinol Diabetes Nutr (Engl Ed). 2023; 70(Suppl. 1): 7-26. doi: https://doi.org/10.1016/j.endien.2022.11.006 (último acceso sept. 2024). DOI: https://doi.org/10.1016/j.endien.2022.11.006